Leboulleux S, Do Cao C, Zerdoud S, Attard M, et al. A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E Mutated Differentiated thyroid Cancer. Clin Cancer Res 2023 Apr 19:CCR-23-0046. doi: 10.1158/1078-0432.CCR-23-0046.
PMID: 37074727